627 related articles for article (PubMed ID: 33172899)
21. The transition of tissue inhibitor of metalloproteinases from -4 to -1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP/TAZ activation.
Shrestha M; Ando T; Chea C; Sakamoto S; Nishisaka T; Ogawa I; Miyauchi M; Takata T
Carcinogenesis; 2019 Oct; 40(10):1288-1297. PubMed ID: 31074490
[TBL] [Abstract][Full Text] [Related]
22. Truncated TEAD-binding protein of TAZ inhibits glioma survival through the induction of apoptosis and repression of epithelial-mesenchymal transition.
Zhao W; Li LW; Tian RF; Dong QF; Li PQ; Yan ZF; Yang X; Huo JL; Fei Z; Zhen HN
J Cell Biochem; 2019 Oct; 120(10):17337-17344. PubMed ID: 31209945
[TBL] [Abstract][Full Text] [Related]
23. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
24. Verteporfin inhibits growth of human glioma in vitro without light activation.
Al-Moujahed A; Brodowska K; Stryjewski TP; Efstathiou NE; Vasilikos I; Cichy J; Miller JW; Gragoudas E; Vavvas DG
Sci Rep; 2017 Aug; 7(1):7602. PubMed ID: 28790340
[TBL] [Abstract][Full Text] [Related]
25. The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype.
Kandasamy S; Adhikary G; Rorke EA; Friedberg JS; Mickle MB; Alexander HR; Eckert RL
Mol Cancer Res; 2020 Mar; 18(3):343-351. PubMed ID: 31732616
[TBL] [Abstract][Full Text] [Related]
26. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
[TBL] [Abstract][Full Text] [Related]
27. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma.
Zhou X; Chen N; Xu H; Zhou X; Wang J; Fang X; Zhang Y; Li Y; Yang J; Wang X
J Hematol Oncol; 2020 Jun; 13(1):77. PubMed ID: 32546241
[TBL] [Abstract][Full Text] [Related]
28. YAP/TAZ maintain the proliferative capacity and structural organization of radial glial cells during brain development.
Lavado A; Gangwar R; Paré J; Wan S; Fan Y; Cao X
Dev Biol; 2021 Dec; 480():39-49. PubMed ID: 34419458
[TBL] [Abstract][Full Text] [Related]
29. A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.
Hillen H; Candi A; Vanderhoydonck B; Kowalczyk W; Sansores-Garcia L; Kesikiadou EC; Van Huffel L; Spiessens L; Nijs M; Soons E; Haeck W; Klaassen H; Smets W; Spieser SA; Marchand A; Chaltin P; Ciesielski F; Debaene F; Chen L; Kamal A; Gwaltney SL; Versele M; Halder GA
Mol Cancer Ther; 2024 Jan; 23(1):3-13. PubMed ID: 37748190
[TBL] [Abstract][Full Text] [Related]
30. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.
Bhat KP; Salazar KL; Balasubramaniyan V; Wani K; Heathcock L; Hollingsworth F; James JD; Gumin J; Diefes KL; Kim SH; Turski A; Azodi Y; Yang Y; Doucette T; Colman H; Sulman EP; Lang FF; Rao G; Copray S; Vaillant BD; Aldape KD
Genes Dev; 2011 Dec; 25(24):2594-609. PubMed ID: 22190458
[TBL] [Abstract][Full Text] [Related]
31. Yes-Associated Protein Nuclear Translocation Is Regulated by Epidermal Growth Factor Receptor Activation Through Phosphatase and Tensin Homolog/AKT Axis in Glioblastomas.
Masliantsev K; Mordrel M; Banor T; Desette A; Godet J; Milin S; Wager M; Karayan-Tapon L; Guichet PO
Lab Invest; 2023 May; 103(5):100053. PubMed ID: 36801645
[TBL] [Abstract][Full Text] [Related]
32. Targeting YAP-p62 signaling axis suppresses the EGFR-TKI-resistant lung adenocarcinoma.
Park HS; Lee DH; Kang DH; Yeo MK; Bae G; Lee D; Yoo G; Kim JO; Moon E; Huh YH; Lee SH; Jo EK; Cho SY; Lee JE; Chung C
Cancer Med; 2021 Feb; 10(4):1405-1417. PubMed ID: 33486901
[TBL] [Abstract][Full Text] [Related]
33. Role of the YAP/TAZ-TEAD Transcriptional Complex in the Metabolic Control of TRAIL Sensitivity by the Mevalonate Pathway in Cancer Cells.
El Yousfi Y; Mora-Molina R; López-Rivas A; Yerbes R
Cells; 2023 Sep; 12(19):. PubMed ID: 37830584
[TBL] [Abstract][Full Text] [Related]
34. The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma.
Lui JW; Xiao S; Ogomori K; Hammarstedt JE; Little EC; Lang D
J Cancer; 2019; 10(1):1-10. PubMed ID: 30662519
[TBL] [Abstract][Full Text] [Related]
35. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139
[TBL] [Abstract][Full Text] [Related]
36. Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway.
Gibault F; Bailly F; Corvaisier M; Coevoet M; Huet G; Melnyk P; Cotelle P
ChemMedChem; 2017 Jun; 12(12):954-961. PubMed ID: 28334506
[TBL] [Abstract][Full Text] [Related]
37. Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation.
Wei C; Li X
BMC Cancer; 2020 Oct; 20(1):1042. PubMed ID: 33121449
[TBL] [Abstract][Full Text] [Related]
38. Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth.
Hu L; Shen D; Liang D; Shi J; Song C; Jiang K; Menglin Ren ; Du S; Cheng W; Ma J; Li S; Bi X; Barr MP; Fang Z; Xu Q; Li W; Piao H; Meng S
Cancer Lett; 2020 Nov; 493():156-166. PubMed ID: 32860853
[TBL] [Abstract][Full Text] [Related]
39. A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.
Al-Mayhani TF; Heywood RM; Vemireddy V; Lathia JD; Piccirillo SGM; Watts C
Neuro Oncol; 2019 Jun; 21(6):719-729. PubMed ID: 30590711
[TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis and Evaluation of a Series of 1,5-Diaryl-1,2,3-triazole-4-carbohydrazones as Inhibitors of the YAP-TAZ/TEAD Complex.
Gibault F; Sturbaut M; Coevoet M; Pugnière M; Burtscher A; Allemand F; Melnyk P; Hong W; Rubin BP; Pobbati AV; Guichou JF; Cotelle P; Bailly F
ChemMedChem; 2021 Sep; 16(18):2823-2844. PubMed ID: 34032019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
